AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS: Form 990, tax year 2015

View the entire original 990 at ProPublica ↗

Organization
AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS (EIN 23-1682043)
Tax period
2015-01-01 to 2015-12-31
Filed
2016-10-04
IRS object ID
201612789349300321
Schema version
2015v2.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2016-10-04T11:26:19-05:00ReturnTs
Tax Period End2015-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN521855942PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1Tate and TryonBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line12021 L Street NW Suite 400AddressLine1Txt
CityWashingtonCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20036ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2015-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN231682043EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1American Society For ClinicalBusinessNameLine1Txt
Business Name Line2Pharmacology and TherapeuticsBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlAMERBusinessNameControlTxt
Phone7038366981PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1528 NORTH WASHINGTON STREETAddressLine1Txt
CityALEXANDRIACityNm
State AbbreviationVAStateAbbreviationCd
ZIP22314ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
Personsharon swanPersonNm
Person TitleChief Executive OfficerPersonTitleTxt
Phone7038366981PhoneNum
Signature2016-10-04SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonR Michael SorrellsPreparerPersonNm
PTINP00001737PTIN
Phone2022932200PhoneNum
FieldValueIRS element (for citing)
Tax2015TaxYr
Build TS2017-02-10 21:41:12ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerSharon SwanPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1528 NORTH WASHINGTON STREETAddressLine1Txt
CityALEXANDRIACityNm
State AbbreviationVAStateAbbreviationCd
ZIP22314ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$3,512,564GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.ASCPT.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1900FormationYr
Legal Domicile StateDCLegalDomicileStateCd
Activity Or MissionADVANCING CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE AND THERAPEUTICS FOR THE BENEFIT OF PATIENTS AND SOCIETY.ActivityOrMissionDesc
Voting Members Governing Body11VotingMembersGoverningBodyCnt
Voting Members Independent11VotingMembersIndependentCnt
Total Employee11TotalEmployeeCnt
Total Volunteers322TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$46,169PYContributionsGrantsAmt
CY Contributions Grants$30,259CYContributionsGrantsAmt
PY Program Service Revenue$2,387,231PYProgramServiceRevenueAmt
CY Program Service Revenue$1,844,898CYProgramServiceRevenueAmt
PY Investment Income$83,339PYInvestmentIncomeAmt
CY Investment Income$92,934CYInvestmentIncomeAmt
PY Other Revenue$797,251PYOtherRevenueAmt
CY Other Revenue$967,504CYOtherRevenueAmt
PY Total Revenue$3,313,990PYTotalRevenueAmt
CY Total Revenue$2,935,595CYTotalRevenueAmt
PY Grants And Similar Paid$39,000PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$22,500CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$984,084PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$1,093,031CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$3,782PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$819CYTotalFundraisingExpenseAmt
PY Other Expenses$1,742,432PYOtherExpensesAmt
CY Other Expenses$2,137,606CYOtherExpensesAmt
PY Total Expenses$2,769,298PYTotalExpensesAmt
CY Total Expenses$3,253,137CYTotalExpensesAmt
PY Revenues Less Expenses$544,692PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$317,542CYRevenuesLessExpensesAmt
Total Assets BOY$5,813,029TotalAssetsBOYAmt
Total Assets EOY$5,370,032TotalAssetsEOYAmt
Total Liabilities BOY$218,211TotalLiabilitiesBOYAmt
Total Liabilities EOY$172,125TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$5,594,818NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$5,197,907NetAssetsOrFundBalancesEOYAmt
MissionAdvancing clinical pharmacology, translational medicine and therapeutics for the benefit of patients and society.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$1,623,185ExpenseAmt
Grant$22,500GrantAmt
Revenue$1,261,055RevenueAmt
DescAnnual Meeting: THE ASCPT ANNUAL MEETING IS AN INTERNATIONAL MEETING THAT ATTRACTS PARTICIPANTS FROM AROUND THE WORLD. A SPECTRUM OF TOPICS RELATING TO THE CONTINUUM OF DRUG DISCOVERY, DEVELOPMENT, REGULATION, AND UTILIZATION ARE DISCUSSED. THE MEETING OFFERS EDUCATIONAL SESSIONS AND POSTER PRESENTATIONS, LECTURES FROM TOP PROFESSIONALS IN THE INDUSTRY, AS WELL AS NETWORKING OPPORTUNITIES WITH CLINICAL PHARMACOLOGISTS FROM AROUND THE WORLD. THERE IS ALSO AN EXHIBIT HALL WITH REPRESENTATIVES FROM VARIOUS COMPANIES.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$1,061,549ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescJournal: CLINICAL PHARMACOLOGY AND THERAPEUTICS (CPT) IS THE AUTHORITATIVE CROSS-DISCIPLINARY JOURNAL IN EXPERIMENTAL AND CLINICAL MEDICINE DEVOTED TO PUBLISHING ADVANCES IN THE NATURE, ACTION, EFFICACY AND EVALUATION OF THERAPEUTICS. IT CONTINUES TO SEE IMPROVEMENTS IN THE NUMBER OF MANUSCRIPTS RECEIVED AND INCREASES IN SUBSCRIPTIONS.CPT: PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY (CPT:PSP) IS AN ONLINE, FULLY OPEN ACCESS JOURNAL. CPT:PSP PROVIDES A UNIQUE INTERNATIONAL FORUM FOR SCIENTISTS IN THE PHARMACOMETRICS AND SYSTEMS PHARMACOLOGY SPACE.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$409,882ExpenseAmt
Grant$0GrantAmt
Revenue$583,843RevenueAmt
DescMember Services: MEMBERSHIP IN ASCPT OFFERS A NUMBER OF BENEFITS WHICH DIRECTLY IMPACT ITS MEMBERS AND THEIR PROFESSIONAL DEVELOPMENT. IT PROVIDES A VARIETY OF INFORMATION TOOLS, SUCH AS THE CPT JOURNAL, WEBSITE AND EMAIL NEWSLETTER, EDUCATIONAL OPPORTUNITIES, SUCH AS THE ANNUAL MEETING, AND PROFESSIONAL DEVELOPMENT OPPORTUNITIES.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$3,094,616TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B Required0ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent EndowmentsYes (1)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To Organizations0GrantsToOrganizationsInd
Grants To IndividualsYes (1)GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document50IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee11EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members11GoverningBodyVotingMembersCnt
Independent Voting Member11IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or StockholdersYes (1)MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To ApprovaYes (1)DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1The SocietyBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone7038366981PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1528 NORTH WASHINGTON STREETAddressLine1Txt
CityALEXANDRIACityNm
State AbbreviationVAStateAbbreviationCd
ZIP22314ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (13 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
MARIO ROCCI JR PHD
PRESIDENT5.00Yes (X)Yes (X)$0$0$0
Julie A Johnson PharmD
PRESIDENT-ELECT5.00Yes (X)Yes (X)$0$0$0
David Y Mitchell PhD
IMMEDIATE PAST PRESIDENT5.00Yes (X)Yes (X)$0$0$0
Gregory L Kearns PHARMDPHD
SECRETARY/TREASURER5.00Yes (X)Yes (X)$0$0$0
KIM L ROWSE BROUWER PHARMD PHD
Board Member5.00Yes (X)$0$0$0
MAURICE EMERY PHARMD PHD
Board Member5.00Yes (X)$0$0$0
Anne C Heatherington PhD
BOARD Member5.00Yes (X)$0$0$0
Sean Hennessy PharmD PhD
BOard Member5.00Yes (X)$0$0$0
WALTER KRAFT MD FACP
Board Member5.00Yes (X)$0$0$0
KELLIE SCHOOLAR REYNOLDS PHARMD
Board Member5.00Yes (X)$0$0$0
Anne Zajicek MD PharmD
Board Member5.00Yes (X)$0$0$0
Sharon J Swan
chief executive officer40.00Yes (X)$401,745$0$42,205
Elise S Laffman-Johnson
Chief Operating Officer40.00Yes (X)$157,500$0$0
FieldValueIRS element (for citing)
Total Reportable Comp From Org$559,245TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$42,205TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K2IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1FREEMAN AUDIO VISUAL INCBusinessNameLine1Txt

Contractor Address ContractorAddress

US Address USAddress

FieldValueIRS element (for citing)
Address Line1PO BOX 650519AddressLine1Txt
CityDALLASCityNm
State AbbreviationTXStateAbbreviationCd
ZIP752650519ZIPCd
FieldValueIRS element (for citing)
ServicesAUDIO VISUAL SERVICESServicesDesc
Compensation$247,647CompensationAmt
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K1CntrctRcvdGreaterThan100KCnt
All Other Contributions$30,259AllOtherContributionsAmt
Total Contributions$30,259TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (4 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
Annual Meeting Registr900099$1,054,595$1,054,595
Membership Dues900099$583,843$583,843
Exhibits900099$173,120$173,120
AM Sponsorships900099$33,340$33,340
FieldValueIRS element (for citing)
Total Program Service Revenue$1,844,898TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$89,487TotalRevenueColumnAmt
Exclusion$89,487ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$963,955TotalRevenueColumnAmt
Exclusion$963,955ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$580,416SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$576,969SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$3,447SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$3,447TotalRevenueColumnAmt
Exclusion$3,447ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescMiscellaneousDesc
Business900099BusinessCd
Total Revenue Column$3,549TotalRevenueColumnAmt
Exclusion$3,549ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$3,549OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,935,595TotalRevenueColumnAmt
Related Or Exempt Func Income$1,844,898RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$1,060,438ExclusionAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$22,500TotalAmt
Program Services$22,500ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$601,450TotalAmt
Program Services$473,073ProgramServicesAmt
Management And General$128,377ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$430,675TotalAmt
Program Services$340,680ProgramServicesAmt
Management And General$89,995ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$20,543TotalAmt
Program Services$8,564ProgramServicesAmt
Management And General$11,979ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$40,363TotalAmt
Program Services$34,167ProgramServicesAmt
Management And General$6,196ManagementAndGeneralAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$33,585TotalAmt
Management And General$33,585ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$23,000TotalAmt
Management And General$23,000ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$94,203TotalAmt
Management And General$94,203ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$19,889TotalAmt
Management And General$19,889ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$157,833TotalAmt
Program Services$157,833ProgramServicesAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$111,182TotalAmt
Program Services$86,637ProgramServicesAmt
Management And General$24,545ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$34,014TotalAmt
Management And General$34,014ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$49,159TotalAmt
Management And General$49,159ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$92,891TotalAmt
Program Services$76,762ProgramServicesAmt
Management And General$16,129ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$900,031TotalAmt
Program Services$900,031ProgramServicesAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$52,905TotalAmt
Management And General$52,905ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$43,221TotalAmt
Management And General$43,221ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
AWARDS/HONORARIUM$215,970$206,970$9,000
STRATEGIC PLAN$144,507$16,291$128,216
EDITORIAL EXPENSES$96,735$96,735
EQUIPMENT$27,957$27,957

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$40,524TotalAmt
Program Services$674,373ProgramServicesAmt
Management And General-$634,668ManagementAndGeneralAmt
Fundraising$819FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$3,253,137TotalAmt
Program Services$3,094,616ProgramServicesAmt
Management And General$157,702ManagementAndGeneralAmt
Fundraising$819FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$218,606BOYAmt
EOY$149,221EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,683,025BOYAmt
EOY$1,243,078EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$1,905BOYAmt
EOY$4,252EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$1,107,518LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$366,859LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$763,421BOYAmt
EOY$740,659EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$2,573,677BOYAmt
EOY$2,682,302EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$572,395BOYAmt
EOY$550,520EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$5,813,029BOYAmt
EOY$5,370,032EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$41,342BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$176,869BOYAmt
EOY$131,534EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$40,591EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$218,211BOYAmt
EOY$172,125EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$5,327,034BOYAmt
EOY$4,933,383EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$267,784BOYAmt
EOY$264,524EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$5,594,818BOYAmt
EOY$5,197,907EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$5,813,029BOYAmt
EOY$5,370,032EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$317,542ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$79,369NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting OtherYes (X)MethodOfAccountingOtherInd
Accountant Compile Or ReviewYes (1)AccountantCompileOrReviewInd

Acct Compile Or Review Basis AcctCompileOrReviewBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
FS Audited0FSAuditedInd
Audit Committee0AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$780,211CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$727,314CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$652,399CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$696,289CurrentTaxYearMinus1YearAmt
Current Tax Year$614,102CurrentTaxYearAmt
Total$3,470,315TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$780,211CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$727,314CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$652,399CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$696,289CurrentTaxYearMinus1YearAmt
Current Tax Year$614,102CurrentTaxYearAmt
Total$3,470,315TotalAmt
FieldValueIRS element (for citing)
Public Support Total170$3,470,315PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$854,059CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,074,743CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,041,798CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,056,745CurrentTaxYearMinus1YearAmt
Current Tax Year$1,053,442CurrentTaxYearAmt
Total$5,080,787TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$11,067CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$14,358CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$14,302CurrentTaxYearMinus2YearsAmt
Total$39,727TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$6,537CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$18,301CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,885CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$31,241CurrentTaxYearMinus1YearAmt
Current Tax Year$3,549CurrentTaxYearAmt
Total$61,513TotalAmt
FieldValueIRS element (for citing)
Total Support$8,652,342TotalSupportAmt
Gross Receipts Rltd Activities$6,468,673GrossReceiptsRltdActivitiesAmt
Public Support CY1700.40110PublicSupportCY170Pct
Public Support PY1700.41470PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule A, Part II, Line 10, Explanation of Other Income:FormAndLineReferenceDesc
ExplanationIncome from Activities not Normally RecurringExplanationTxt

Schedule C IRS990ScheduleC

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$3,233,248FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$3,233,248FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$311,662FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$77,916FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$296,968CurrentYearMinus3Amt
Current Year Minus2$281,814CurrentYearMinus2Amt
Current Year Minus1$287,046CurrentYearMinus1Amt
Current Year$311,662CurrentYearAmt
Total$1,177,490TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$1,766,235LobbyingCeilingAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$74,242CurrentYearMinus3Amt
Current Year Minus2$70,454CurrentYearMinus2Amt
Current Year Minus1$71,762CurrentYearMinus1Amt
Current Year$77,916CurrentYearAmt
Total$294,374TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$441,561GrassrootsCeilingAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$451,852BeginningYearBalanceAmt
Contributions$3,628ContributionsAmt
Investment Earnings Or Losses$781InvestmentEarningsOrLossesAmt
Other Expenditures$10,059OtherExpendituresAmt
Administrative Expenses$3,321AdministrativeExpensesAmt
End Year Balance$442,881EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$471,079BeginningYearBalanceAmt
Contributions$6,043ContributionsAmt
Investment Earnings Or Losses$26,911InvestmentEarningsOrLossesAmt
Other Expenditures$47,961OtherExpendituresAmt
Administrative Expenses$4,220AdministrativeExpensesAmt
End Year Balance$451,852EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$411,569BeginningYearBalanceAmt
Contributions$60,083ContributionsAmt
Investment Earnings Or Losses$45,311InvestmentEarningsOrLossesAmt
Other Expenditures$42,119OtherExpendituresAmt
Administrative Expenses$3,765AdministrativeExpensesAmt
End Year Balance$471,079EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$427,130BeginningYearBalanceAmt
Contributions$59,572ContributionsAmt
Investment Earnings Or Losses$29,502InvestmentEarningsOrLossesAmt
Other Expenditures$101,627OtherExpendituresAmt
Administrative Expenses$3,008AdministrativeExpensesAmt
End Year Balance$411,569EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$400,285BeginningYearBalanceAmt
Contributions$56,125ContributionsAmt
Investment Earnings Or Losses$6,360InvestmentEarningsOrLossesAmt
Other Expenditures$32,767OtherExpendituresAmt
Administrative Expenses$2,873AdministrativeExpensesAmt
End Year Balance$427,130EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.40300BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.00000PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.59700TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org0EndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$186,000OtherCostOrOtherBasisAmt
Book Value$186,000BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$577,816OtherCostOrOtherBasisAmt
Depreciation$178,160DepreciationAmt
Book Value$399,656BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$195,657OtherCostOrOtherBasisAmt
Depreciation$58,245DepreciationAmt
Book Value$137,412BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$122,925OtherCostOrOtherBasisAmt
Depreciation$105,334DepreciationAmt
Book Value$17,591BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$25,120OtherCostOrOtherBasisAmt
Depreciation$25,120DepreciationAmt
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$740,659TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescDUE TO INTERNATIONAL SOCIETY OF PHARMACOMETRICSDesc
Amt$40,591Amt
FieldValueIRS element (for citing)
Total Liability$40,591TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Part V, Line 4:purpose of endowment: THE BOARD OF DIRECTORS HAS DESIGNATED CASH AND INVESTMENTS TO BE SET ASIDE TO MEET AT LEAST THREE MONTHS WORTH OF OPERATING EXPENSES. THE BOARD HAS ALSO DESIGNATED CERTAIN INVESTMENTS AND THE INCOME RELATED TO THOSE INVESTMENTS ACCOUNTS FOR PAYMENT OF THE SOCIETY'S AWARD PROGRAMS AT ITS ANNUAL MEETING. THE AWARDS PROGRAMS FOR WHICH INVESTMENTS HAVE BEEN SET ASIDE INCLUDE THE WILLIAM B. ABRAMS AWARD, THE RAWLS-PALMER AWARD, AND THE SCIENTIFIC AWARDS COMMITTEE.
Part X, Line 2:The Society has evaluated its tax positions for all open tax years. Currently, the tax years open and subject to examination by the Internal Revenue Service are the 2013, 2014, and 2015 tax years. However, the Society is not currently under audit. Based on the evaluation of the Society's tax positions, management believes all tax positions taken would be upheld under an examination. Therefore, no provisions for the effects of uncertain tax positions have been recorded for the year ended December 31, 2015.

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (8 entries)

Grant TypeGrantTypeTxtRecipientRecipientCntCash GrantCashGrantAmt
FDA Abrams Award Lecture1$500
GARY NEIL PRIZE1$2,500
Henry W. Elliot Distinguished Service Award1$1,000
Leon I. Goldberg EARLY Investigator Award1$1,000
Oscar B. Hunter Award1$1,500
RAWLS-PALMER PROGRESS IN MEDICINE AWARD1$1,000
Honorarium-2015 Annual Meeting3$3,000
pres trainee award24$12,000

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePart I, Line 2:FormAndLineReferenceDesc
ExplanationASCPT MAINTAINS RECORDS TO SUBSTANTIATE THE AMOUNT OF GRANTS OR ASSISTANCE, THE GRANTEES' ELIGIBILITY FOR THE GRANTS, AND THE SELECTION CRITERIA USED TO AWARD THE GRANTS. EACH YEAR ASCPT'S AWARDS PROGRAM PROVIDES AN ARRAY OF AWARDS THAT RECOGNIZE OUTSTANDING SCIENCE AND ACHIEVEMENT IN CLINICAL PHARMACOLOGY. ASCPT'S AWARDS SPAN THE CONTINUUM OF CLINICAL PHARMACOLOGY, TRANSLATIONAL MEDICINE, AND THERAPEUTICS. THE ARRAY OF AWARDS IS DESIGNED TO RECOGNIZE EVERY TURNING POINT IN THE CAREER PATH FROM YOUNG INVESTIGATOR TO SEASONED SCIENTIST WITH THE FOCUS ON EXCEPTIONAL ACHIEVEMENTS IN THE DIMENSIONS THAT THE AWARDS ARE FOCUSED. CANDIDATES ARE NOMINATED BY COLLEAGUES FOR CONSIDERATION FOR AN ASCPT AWARD. ALL NOMINATIONS ARE VETTED BY AN APPOINTED AWARDS SELECTION TASK FORCE COMPRISED OF ASCPT MEMBERS. LETTERS OF RECOMMENDATION AND CURRICULUM VITAE ARE REVIEWED AND ULTIMATELY DECISIONS ARE MADE BY THE AWARDS SELECTION TASK FORCE ON EACH RECIPIENT OF AN ASCPT AWARD. GARY NEIL PRIZE FOR INNOVATION IN DRUG DEVELOPMENT ELIGIBILITY: INDIVIDUALS AS WELL AS TEAMS WHO HAVE DEMONSTRATED LEADERSHIP IN THE APPLICATION OF SIGNIFICANT, INNOVATIVE SCIENCE TO CLINICAL DRUG DEVELOPMENT. THE AWARD IS OPEN TO INDIVIDUALS FROM ALL CLINICAL PHARMACOLOGY EMPLOYMENT SECTORS. PRIZE AND PRESENTATION: THE GARY NEIL PRIZE FOR INNOVATION IN DRUG DEVELOPMENT WILL BE PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL RECEIVE A PLAQUE AND A $2,500 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. LEON I. GOLDBERG EARLY INVESTIGATOR AWARD* *PREVIOUSLY LEON I. GOLDBERG YOUNG INVESTIGATOR AWARD FROM 1986-2015 ELIGIBILITY: THE NOMINEE CAN BE AN ACADEMIC, INDUSTRIAL, OR REGULATORY SCIENTIST WHO HAS MADE A SUBSTANTIAL CONTRIBUTION TO CLINICAL PHARMACOLOGY WITHIN 10 YEARS OF THE COMPLETION OF AN ADVANCED DEGREE AND/OR A POST-DOCTORAL FELLOWSHIP OR RESIDENCY PROGRAM. AN IMPORTANT ASPECT IS THAT THE RECIPIENT WILL BE ABLE TO DELIVER AN ENGAGING PRESENTATION ABOUT THE IMPACT OF HIS/HER RESEARCH. THE AWARD IS INTENDED TO FOSTER THE CANDIDATE'S POTENTIAL FOR SIGNIFICANT CONTRIBUTIONS TO THE FUTURE OF CLINICAL PHARMACOLOGY. THE NOMINATOR'S ASSESSMENT AND LETTERS OF RECOMMENDATION SHOULD CONTAIN EVIDENCE THAT THE CANDIDATE HAS DOCUMENTED SCIENTIFIC CONTRIBUTIONS, AS EVIDENCED BY EITHER WELL CITED PUBLICATIONS, GRANTS, PATENTS, INDEPENDENT INFLUENCE ON IMPORTANT DRUG DEVELOPMENT OR REGULATORY DECISIONS, OR OTHER RECOGNITIONS AS MAY BE RELEVANT. THERE ARE NO RESTRICTIONS CONCERNING THE SCIENTIFIC FIELD IN WHICH NOMINEES HAVE EARNED THEIR DOCTORAL DEGREES. ALTHOUGH IT IS ENCOURAGED, A NOMINEE NEED NOT BE A MEMBER OF THE SOCIETY. PRIZE AND PRESENTATION: THE LEON I. GOLDBERG EARLY INVESTIGATOR AWARD IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL DELIVER A LECTURE ON HIS/HER WORK. IN ADDITION, THE RECIPIENT OF THE AWARD WILL RECEIVE A PLAQUE AND A $1,000 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION ARE REIMBURSED BY THE SOCIETY. OSCAR B. HUNTER CAREER AWARD IN THERAPEUTICS* *PREVIOUSLY OSCAR B. HUNTER MEMORIAL AWARD FROM 1955-2015 ELIGIBILITY: THE NOMINEE CAN BE AN ACADEMIC, INDUSTRIAL, OR REGULATORY SCIENTIST WHO HAS DEMONSTRATED A SUSTAINED RECORD OF LIFELONG CONTRIBUTIONS TO CLINICAL PHARMACOLOGY AND DISSEMINATION OF KNOWLEDGE WHO WILL BE ABLE TO GIVE AN ENGAGING PRESENTATION ABOUT HIS/HER CAREER AND THE IMPACT OF HIS/HER WORK. THE NOMINATOR'S ASSESSMENT AND LETTERS OF RECOMMENDATION SHOULD PROVIDE EVIDENCE OF THE NOMINEE'S EXEMPLARY CAREER AS A LEADER, INCLUDING SUFFICIENT DOCUMENTED SCIENTIFIC CONTRIBUTIONS, AS EVIDENCED BY EITHER HIGH IMPACT PUBLICATIONS, PATENTS, INDEPENDENT INFLUENCE ON IMPORTANT DRUG DISCOVERY, DRUG DEVELOPMENT OR REGULATORY DECISIONS, OR OTHER RECOGNITIONS AS MAY BE RELEVANT. PARTICULAR EMPHASIS SHOULD BE PROVIDED ON THE LIFETIME CONTRIBUTIONS OF THIS NOMINEE AND THE IMPACT OF HIS/HER ACCOMPLISHMENT TO CLINICAL PHARMACOLOGY. THE NOMINEE MUST BE A WELL-RECOGNIZED LEADER IN CLINICAL PHARMACOLOGY, BUT DOES NOT NEED TO BE AN ASCPT MEMBER. PRIZE AND PRESENTATION: THE OSCAR B. HUNTER CAREER AWARD IN THERAPEUTICS IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL PRESENT A LECTURE SUMMARIZING THE WORKS THAT FORM THE BASIS OF THE AWARD. IN ADDITION, THE RECIPIENT OF THE AWARD WILL RECEIVE A BRONZE MEDAL MOUNTED ON A PLAQUE AND A $1,500 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. RAWLS-PALMER PROGRESS IN MEDICINE AWARD ELIGIBILITY: A NOMINEE CAN BE AN ACADEMIC, INDUSTRIAL, OR REGULATORY SCIENTIST WHO IS WIDELY RECOGNIZED FOR HIS/HER TRANSFORMATIONAL AND/OR TRANSLATIONAL DISCOVERIES OR INNOVATIVE APPROACHES IMPACTING CLINICAL PHARMACOLOGY RESEARCH AND CLINICAL PRACTICE. THE NOMINATOR'S ASSESSMENT AND LETTER(S) OF RECOMMENDATION SHOULD PROVIDE EVIDENCE OF THE NOMINEE'S EXEMPLARY RECORD, INCLUDING SUFFICIENT DOCUMENTED SCIENTIFIC CONTRIBUTIONS FROM RESEARCH THAT LEAD TO DIRECT APPLICATIONS IN PATIENT CARE, AS EVIDENCED BY EITHER WELL CITED PUBLICATIONS, PATENTS, INDEPENDENT INFLUENCE ON IMPORTANT DRUG DEVELOPMENT OR REGULATORY DECISIONS, OR OTHER RECOGNITIONS (AS MAY BE RELEVANT). A NOMINEE DOES NOT NEED TO BE AN ASCPT MEMBER. PRIZE AND PRESENTATION: THE RAWLS-PALMER PROGRESS IN MEDICINE AWARD IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL PRESENT A LECTURE FOCUSING ON RECENT DEVELOPMENTS IN CLINICAL PHARMACOLOGY. IN ADDITION, THE RECIPIENT WILL RECEIVE A $1,000 PRIZE AND A PLAQUE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. SHEINER-BEAL PHARMACOMETRICS AWARD ELIGIBILITY: THE CANDIDATE MUST BE AN INVESTIGATOR OR LEADER WHO IS ACTIVELY ADVANCING THE SCIENTIFIC DISCIPLINE OF PHARMACOMETRICS AND/OR ITS IMPACT ON RESEARCH, DEVELOPMENT, REGULATORY EVALUATION, OR UTILIZATION OF THERAPEUTIC PRODUCTS, AND IS CAPABLE OF DELIVERING AN ENGAGING AND COMPREHENSIVE LECTURE ON PHARMACOMETRICS. THE AWARD IS INTENDED TO RECOGNIZE CLINICAL PHARMACOLOGISTS, CLINICIAN SCIENTISTS, COMPUTATIONAL SCIENTISTS, STATISTICIANS AND OTHERS IN ACADEMIA, INDUSTRY, GOVERNMENT AGENCIES, OR CONSULTING WHOSE WORK FALLS WITHIN THE SCOPE OF THE DEFINITION OF PHARMACOMETRICS. PRIZE AND PRESENTATION: THE SHEINER-BEAL PHARMACOMETRICS AWARD WILL BE PRESENTED ANNUALLY AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL PRESENT A LECTURE SUMMARIZING THE WORKS THAT FORM THE BASIS OF THE AWARD. IN ADDITION, THE RECIPIENT WILL RECEIVE A $1,500 PRIZE AND A PLAQUE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. WILLIAM B. ABRAMS AWARD IN GERIATRIC CLINICAL PHARMACOLOGY ELIGIBILITY: A NOMINEE MUST BE AN INVESTIGATOR IN GERIATRICS WHO IS ACTIVELY INVOLVED IN HIGH-QUALITY TEACHING AND RESEARCH IN GERIATRIC CLINICAL PHARMACOLOGY. PRIZE AND PRESENTATION: THE WILLIAM B. ABRAMS AWARD IN GERIATRIC CLINICAL PHARMACOLOGY IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL RECEIVE A PLAQUE AND A $1,000 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY. HENRY W. ELLIOTT DISTINGUISHED SERVICE AWARD ELIGIBILITY: A NOMINEE MUST BE A MEMBER OF ASCPT AND CANNOT HAVE HELD THE POSITION OF PRESIDENT-ELECT OR PRESIDENT OF THE SOCIETY WITHIN THE LAST FIVE YEARS. THE ESSENTIAL CRITERION IS DOCUMENTED EVIDENCE OF EXCELLENT SERVICE TO THE ORGANIZATION. ONE OR TWO OUTSTANDING ACTS OF SERVICE OR A LONG RECORD OF MANY ACTS OF SERVICE MAY JUSTIFY THE AWARD. THE RECIPIENT SHOULD HAVE A RECORD OF CONTINUOUS SERVICE TO THE SOCIETY, INCLUDING ONE OR MANY MAJOR ACCOMPLISHMENTS. PRIZE AND PRESENTATION: THE HENRY W. ELLIOTT DISTINGUISHED SERVICE AWARD IS PRESENTED AT THE ASCPT ANNUAL MEETING. THE RECIPIENT WILL RECEIVE A PLAQUE AND A $1,000 PRIZE. TRAVEL EXPENSES, HOTEL EXPENSES AND MEETING REGISTRATION WILL BE REIMBURSED BY THE SOCIETY.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (2 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Sharon J Swan
chief executive officer$349,997$0$51,748$0$0$0$35,000$0$7,205$0$443,950$0$0$0
Elise S Laffman-Johnson
Chief Operating Officer$150,000$0$7,500$0$0$0$0$0$0$0$157,500$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePart I, Line 7FormAndLineReferenceDesc
ExplanationThe process for calculating the staff bonus is dependent on performance and discussions with the Compensation Committee and the CEO. The CEO's bonus is calculated based on achievement of incentive objectives that are approved by the Compensation Committee.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part VI, Section A, line 6The Society has two classes of members: FUll Member and Trainee/Student Member Full Member: For applicants who have earned a doctorate degree or equivalent in any of the biomedical sciences. Also for applicants in executive and leadership roles in related organizations. Applicants must demonstrate a sincere interest in, and contributions to, human pharmacology and therapeutics through publications, grants, patents, governmental reports, company reports, etc. Trainee/STudent Member: For applicants currently enrolled in a post-doctoral training program who have demonstrated an interest in human pharmacology and therapeutics. Also for applicants who are pursuing a post-baccalaureate degree and who possess an interest in human pharmacology and therapeutics.
Form 990, Part VI, Section A, line 7aMembers shall have such voting privileges as are determined from time to time by the Society's Governing Board and shall vote in such manner as determined by the Governing Board.
Form 990, Part VI, Section A, line 7bAny changes to the organization's bylaws are subject to approval by the full members.
Form 990, Part VI, Section B, line 11The Form 990 is reviewed by the ASCPT Executive Director and ASCPT legal counsel following preparation by the Society's accountants. The officers of ASCPT review the document prior to it being filed. The Board is informed about the preparation and filing of the Form 990 and the return is made available at any time to any Board Member for his or her review.
Form 990, Part VI, Section B, line 12cALL ASCPT VOLUNTEER LEADERS COMPLETE A WRITTEN CONFLICT OF INTEREST DISCLOSURE. THE CEO, LEGAL COUNSEL, AND SENIOR STAFF ARE AWARE OF CONFLICTS, AND DISCUSS ANY ACTUAL OR POTENTIAL COI ISSUES. CONFLICT OF INTEREST IS DISCUSSED AT THE BEGINNING OF EVERY BOARD OF DIRECTORS CONFERENCE CALL, WITH BOARD MEMBERS BEING ASKED TO DECLARE ANY CONFLICTS AT THE BEGINNING OF THE CALL.
Form 990, Part VI, Section B, line 15THE EXECUTIVE DIRECTOR'S COMPENSATION IS DETERMINED BY THE ASCPT COMPENSATION COMMITTEE USING COMPARABILITY DATA. COMPENSATION OF KEY EMPLOYEES IS DETERMINED BY THE EXECUTIVE DIRECTOR USING COMPARABILITY DATA.
Form 990, Part VI, Section C, line 19The governing documents and conflict of interest policy are available on the ASCPT website. Financial statements are available upon request.
Form 990, Part XII, Line 1:THE SOCIETY PREPARES ITS FINANCIAL STATEMENTS ON THE MODIFIED CASH BASIS OF ACCOUnTING. REVENUES ARE RECOGNIZED WHEN COLLECTED RATHER THAN WHEN EARNED, AND EXPENSES ARE GENERALLY RECOGNIZED WHEN PAID RATHER THAN WHEN INCURRED. THE MODIFIED CASH BASIS OF ACCOUNTING INCLUDES THE RECORDING OF DEPRECIATION ON PROPERTY AND EQuipMENT, AND REALIZED AND UNREALIZED GAINS AND LOSSES ON INVESTMENTS.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.